Navigation Links
Treatment Corrects Severe Insulin Imbalance in Animal Studies
Date:7/31/2008

Much of its work builds on pioneering research by Charles A. Stanley, M.D., in identifying the specific gene defects that cause HI. Stanley is a co-author of the current study.

The National Institutes of Health, the American Diabetes Association and the Penn Diabetes Center supported the study. In addition to Charles Stanley, De Leon's co-authors were Changhong Li, M.D., and Madeleine I. Delson, both of Children's Hospital; and Doris A. Stoffers, M.D., Ph.D., and Franz M. Matschinsky, M.D., both of the Institute of Diabetes, Obesity and Metabolism (IDOM) at the University of Pennsylvania School of Medicine. De Leon and Stanley also are members of IDOM.

About The Children's Hospital of Philadelphia: The Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country, ranking third in National Institutes of Health funding. In addition, its unique family-centered care and public service programs have brought the 430-bed hospital recognition as a leading advocate for children and adolescents. For more information, visit http://www.chop.edu.

Contact: John Ascenzi

Phone: (267) 426-6050

Ascenzi@email.chop.edu


'/>"/>
SOURCE The Children's Hospital of Philadelphia
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Study Reveals Novel LCD Solution Provides Significant Benefits Versus Calcipotriol In Treatment Of Moderate Psoriasis
2. First Ever Study on Alzheimers Disease Treatment in Hispanics Presented at Major Medical Meeting
3. Four Alzheimers Clinical Trials Address a Variety of Treatment Targets - Amyloid, Tau, Synapse Formation
4. Findings on Bladder-Brain Link May Point to Better Treatments for Problems in Sleep, Attention
5. BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
6. Two New Alzheimers Disease Studies Show Advances Against Different Treatment Targets
7. Polyphenon Pharma Receives Orphan Drug Designation for Its Botanical Drug, Polyphenon E, for the Treatment of CLL
8. Journal of Clinical Oncology Article Highlights CellSearch(TM) Circulating Tumor Cell Test in Treatment of Metastatic Colorectal Cancer
9. MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis
10. InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)
11. Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...25 Pharmasset, Inc. (Nas...any committed to discovering, developing and comme...reported financial results for the fiscal year end...asset held $58.4 million in cash, cash equivalents...te and 2009 Highlights ,, RG7128 ,, Pha...
(Date:11/25/2009)...zerland, Nov. 25 From November 16...e hearing solutions, presented the second edition ...g on the special needs of the older population. Th...ging and audiology from around the world and more ...eople with hearing loss for an opportunity to shar...
(Date:11/25/2009)...25 The FDA granted traditional app...non-nucleoside reverse transcriptase inhibitor (NN...icated for use in treatment-experienced adults who...ains resistant to an NNRTI and other antiretrovira... on 48-week data from two Phase 3 studies known as...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5ULURU Inc Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30 2009 and to Provide a Business Update 5953 1ULURU Inc Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30 2009 and to Provide a Business Update 5953 2Depression May Blur Memory of Aches and Pains 60609 1Depression May Blur Memory of Aches and Pains 60609 2Study of concurrent radiotherapy chemotherapy shows promise in small cell lung cancer 60605 1Study of concurrent radiotherapy chemotherapy shows promise in small cell lung cancer 60605 2Study of concurrent radiotherapy chemotherapy shows promise in small cell lung cancer 60605 3
...- Bayer HealthCare,Pharmaceuticals announced today...ron(R) (interferon beta-1b), presented this week,a...nnual Meeting,demonstrating early efficacy, long-...ith treatment in patients with relapsing,forms of ...udies highlight the important clinical,benefits an...
...hange, EDMONTON, May 02, 2007 /PRNewswire-FirstCal...y") Quest is pleased to provide an,update on the p...,of prostate cancer. , Prostate cancer is the seco...ith approximately 230,000 new cases and 30,000 dea...ocalized prostate,cancer are associated with signi...
Other Medicine Technology:Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 2Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 3Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 4Quest PharmaTech's Prostate Cancer Program Update 2Quest PharmaTech's Prostate Cancer Program Update 3
(Date:11/28/2009)... -- Get ready for advanced visualization to bec...en Siemens introduces syngo. via(1) at the ... Radiological Society of North America (RSNA) from...th #825, East Building/Lakeside Center, Hall D) in...maging software for multimodality reading of clini...
(Date:11/28/2009)...cognize signs of depression , , SATURDAY...e holiday season can trigger melancholy as they th...sues or worry about money problems, according to t...ome the seasonal blues, the AGS Foundation for Hea...out and socialize or invite family and friends ove...
(Date:11/27/2009)...ikins Ltd. today issued its latest biochemical ana...at the lethality of the virus has dropped from its... outbreak in the spring of 2009 to resting non-epi... infectivity count, however, remains increased. ,...7, 2009 -- Biotech firm Replikins Ltd., which has ...
(Date:11/27/2009)...swire-USNewswire/ -- Preventing disease is the goa...ery year, new vaccines are being added to assist i...munity for the same period of time? And, if not, w...immunity strong? ,, In this month,s issue of ... Pediatrics, Michael Pichichero MD, Director of th...
(Date:11/27/2009)... has announced that it has become a national spons... nonprofit organizations dedicated to arthritis re... Delray Beach, FL (Vocus) November 27,...company specializing in the marketing and retail d...nnounced today that is has become a national spons...
Breaking Medicine News(10 mins):Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4
...ith eye docs, says researcher , , THURSDAY... expect the eye doctor,s office to be the last pla... recent research suggests that most people would a...ery important to their sense of well-being, accord...
... (Nasdaq:,CYBX) today announced that Dan Moore, Pr...ne, Vice President, Finance and Chief Financial,Of...s Conference in New,York on Wednesday, September 2...S will host a webcast of the presentation,live and...
...ly also has serious consequences for the children,...i from Uppsala University has studied women and th..., among other things, that children whose mothers ...ildren,s Health, monitored more than 3,000 childre...
...., headquartered in,Orlando, FL, a leading provide...e award-winning predictive analytics, announced to...ashville, TN, one of its clients, a state,Medicaid... The presentation will demonstrate how MEDai,s pr...
...er,Services, Inc. (NYSE: ACS ) today announced th...ssistance Program (EPAP), now activated for,reside... Gustav., The EPAP program, established by the Ce...lth insurance living in, or,evacuated from, declar...
...centToSleep.com,which specializes in the productio...il sleep mist, appears on the magazine cover "Arom... "Wish you could sleep like a baby?" was researche...ht., ScentToSleep.com is filling a niche in the s...
Other Medicine News:Health News:Spiritual Beliefs Part of Health Care for Some 2Health News:Spiritual Beliefs Part of Health Care for Some 3Health News:Cyberonics to Present at UBS Global Life Sciences Conference 2Health News:MEDai's Predictive Analytics Impact How State Medicaid Agencies Triage High- Risk Members 2Health News:ACS Facilitates Emergency Prescription Assistance Program Now Activated in Southern Louisiana 2Health News:ScentToSleep.com Is Pleased to Announce That the Company Was Featured in the September 15th Issue of Woman's World Magazine 2
N High Sensitivity CRP
Toothed Pituitary IVD Rongeurs
Micro Decker Pituitary Rongeurs
Doro Skull Clamp
Medicine Products: